Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis. mfm. 2024;26(5). Accessed July 26, 2026. http://medicalforummonthly.com/index.php/mfm/article/view/2774